Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.112821
Revised: September 18, 2025
Accepted: December 2, 2025
Published online: January 27, 2026
Processing time: 173 Days and 10.1 Hours
Core Tip: This review provides a comprehensive overview of hepatic steatosis evaluation methods, ranging from conventional ultrasound and liver biopsy to advanced techniques such as magnetic resonance imaging-derived proton density fat fraction, attenuation-based ultrasound, and emerging blood-based and epigenetic biomarkers. By integrating multimodal diagnostic strategies, including artificial intelligence-assisted imaging and methylation profiling, clinicians can improve the diagnosis, risk stratification, and therapeutic monitoring of metabolic dysfunction-associated steatotic liver disease. The review also highlights the evolving role of steatosis quantification as a treatment response marker and future directions in pr
